BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AV078 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of AV078\, from ClinicalTrials.gov estimates
 .
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07680322-8865@assetmemo.bio
DTSTAMP:20261121T004539Z
DTSTART;VALUE=DATE:20270901
DTEND;VALUE=DATE:20270902
SUMMARY:AV078: Phase 2 readout est. (NCT07680322)
DESCRIPTION:AV078\, phase 2\, Epilepsy.\nStudy: Safety and Efficacy of AV07
 8 in Participants With Tuberous Sclerosis Complex (TSC) Refractory Epileps
 y (RESTOR-1)\nEstimated primary completion: 1 September 2027. This is a Cl
 inicalTrials.gov estimate\, not a confirmed readout date\, and it can move
 .\nDrug page: https://assetmemo.bio/drug/av078#upcoming-events\nRegistry r
 ecord: https://clinicaltrials.gov/study/NCT07680322
URL:https://assetmemo.bio/drug/av078#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
